Alpha Crest Capital Management LLC Sangamo Therapeutics, Inc Transaction History

Alpha Crest Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.28 - $6.21 $47,294 - $89,541	-14,419 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.23 - $7.82 $15,266 - $22,826	2,919 Added 25.38%	14,419 $84,000
Q4 2021 Feb 09, 2022	BUY	$7.29 - $10.97 $7,056 - $10,618	968 Added 9.19%	11,500 $86,000
Q3 2021 Nov 10, 2021	SELL	$9.01 - $12.01 $207,698 - $276,854	-23,052 Reduced 68.64%	10,532 $95,000
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $155,123 - $192,797	15,253 Added 83.21%	33,584 $402,000
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $207,938 - $325,859	-19,112 Reduced 51.04%	18,331 $230,000
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $868,921 - $1.71 Million	-94,141 Reduced 71.54%	37,443 $584,000
Q3 2020 Nov 12, 2020	BUY	$9.38 - $12.48 $943,477 - $1.26 Million	100,584 Added 324.46%	131,584 $1.24 Million
Q2 2020 Aug 12, 2020	BUY	$6.21 - $11.83 $192,510 - $366,730	31,000 New	31,000 $278,000
Q1 2020 May 13, 2020	SELL	$5.05 - $8.85 $51,510 - $90,270	-10,200 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$8.03 - $11.7 $81,906 - $119,340	10,200 New	10,200 $85,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $391M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.